title: [Intravenous immunoglobulin therapy is more and more common. The increasing tempo can force a prioritization of patients, scientists are warning].
authors.forename: P
authors.initials: P
authors.lastname: Orn
mesh_terms: D001327:Autoimmune Diseases / Q000628:therapy*; D006292:Health Priorities; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000737:chemistry / Q000276:immunology; D012106:Research
chemical_list: D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D011961:Receptors, Fc
vernacular_title: Intravenös immunglobulinterapi allt vanligare. Snabb ökningstakt kan tvinga fram patientprioriteringar varnar forskare.